Profitability Ratios
| Ratio |
Value |
| GP Margin |
59.4% |
| EBIT Margin |
32.6% |
| EBITDA Margin |
37.2% |
| Operating Margin |
32.7% |
| Pretax Margin |
32.6% |
| Cont. Ops Margin |
27.2% |
| Net Margin |
27.2% |
| Bottom Line Margin |
27.2% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
3.44 |
| Quick Ratio |
2.53 |
| Solvency Ratio |
0.742 |
| Cash Ratio |
1.19 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
0.72 |
| Forward PEG |
0.72 |
| Price/Book |
6.34 |
| Price/Sales |
7.36 |
| Price/FCF |
22.78 |
| Price/Op Cash Flow |
21.61 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.1042 |
| Debt/Equity |
0.1427 |
| Debt/Capital |
0.1249 |
| Long-Term Debt/Capital |
0.0994 |
| Financial Leverage |
1.37 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
2.62 |
| Operating Cash Flow Ratio |
1.719 |
| Operating Cash Flow/Sales |
34.0% |
| Free Cash Flow/Operating Cash Flow |
94.9% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
72.71 |
| Interest Coverage |
133.6635 |
| Short-Term Operating Cash Flow Coverage |
176.93 |
| Operating Cash Flow Coverage |
2.06 |
| Capital Expenditure Coverage |
19.49 |
| Dividend + Capital Expenditure Coverage |
4.37 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
22.1943% |
| Dividend Yield |
0.8213% |
| Dividend Yield % |
0.8213% |
| Dividend Per Share |
2.1189 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
35.08 |
| EPS |
9.547 |
| Debt/Share |
5.8918 |
| Cash/Share |
8.24 |
| Book Value/Share |
40.68 |
| Tangible BV/Share |
16.74 |
| Equity/Share |
40.68 |
| Operating Cash Flow/Share |
11.939 |
| Capital Expenditure/Share |
0.613 |
| FCF/Share |
11.326 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.835 |
| Earnings Before Tax/EBIT |
0.995 |
| Price/Fair Value |
6.34 |
| Debt/Market Cap |
0.0177 |
| Effective Tax Rate |
16.5% |
| Enterprise Value Multiple |
19.60 |
RMD - ResMed Inc.